Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6325)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hou XF, Xu LP, Song HY, Li S, Wu C, Wang JF. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA. World J Gastroenterol 2017; 23(10): 1796-1803 [PMID: 28348485 DOI: 10.3748/wjg.v23.i10.1796] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i10/1796.htm |
| Number | Citing Articles |
| 1 |
Chengcheng Liao, Qian Wang, Jiaxing An, Minglin Zhang, Jie Chen, Xiaolan Li, Linlin Xiao, Jiajia Wang, Qian Long, Jianguo Liu, Xiaoyan Guan. SPINKs in Tumors: Potential Therapeutic Targets. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.833741
|
| 2 |
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, Luis Felipe Ribeiro Pinto, Nathalia Meireles Da Costa, Antonio Palumbo. Molecular mechanisms associated with chemoresistance in esophageal cancer. Cellular and Molecular Life Sciences 2022; 79(2) doi: 10.1007/s00018-022-04131-6
|
| 3 |
Yanjie You, Shengjuan Hu. Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2022; 46(5): 101891 doi: 10.1016/j.clinre.2022.101891
|
| 4 |
Miguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, Berta Casar, Piero Crespo, Vivian de los Rios, J. Ignacio Casal, Yazan Haddad, Roman Guran, Tomas Eckschlager, Petra Pokorna, Zbynek Heger, Vojtech Adam. Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84185-x
|
| 5 |
Bharath Somasundram, Prasath Manogaran, Madavan Vasudevan, Vijaya Padma Viswanadha. Chemosensitizing effect of neferine on cisplatin-resistant colorectal cancer: Identification of potential candidate genes and pathways through whole transcriptome profiling. Phytomedicine Plus 2022; 2(3): 100299 doi: 10.1016/j.phyplu.2022.100299
|
| 6 |
Harsh Patel, M. Saeed Sheikh, Ying Huang. ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage. Cell Death & Disease 2020; 11(7) doi: 10.1038/s41419-020-2728-1
|
| 7 |
Song Yang, Peng Wang, Songhua Wang, Aihua Cong, Qi Zhang, Wenhao Shen, Xiangyi Li, Wei Zhang, Gaohua Han. <p>miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB</p>. Cancer Management and Research 2020; : 4981 doi: 10.2147/CMAR.S251264
|
| 8 |
Qingchun Mu, Yue Lv, Chunmei Luo, Xiaojing Liu, Chunming Huang, Youcheng Xiu, Longguang Tang. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.709324
|
| 9 |
Junjie Zhao, Niu Niu, Fan Yang, Haitao Liu, Weibo Qi. Preparation, characterisation, and in vitro cancer‐suppression function of RNA nanoparticles carrying miR‐301b‐3p Inhibitor. IET Nanobiotechnology 2023; 17(3): 224 doi: 10.1049/nbt2.12120
|
| 10 |
Miguel Angel Merlos Rodrigo, Ana Maria Jimenez Jimemez, Yazan Haddad, Khaldon Bodoor, Pavlina Adam, Sona Krizkova, Zbynek Heger, Vojtech Adam. Metallothionein isoforms as double agents – Their roles in carcinogenesis, cancer progression and chemoresistance. Drug Resistance Updates 2020; 52: 100691 doi: 10.1016/j.drup.2020.100691
|
| 11 |
Zaiye Li, Canhua Jiang, Yongxiang Yuan, Muy-Teck Teh. TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma. PLOS ONE 2019; 14(5): e0216834 doi: 10.1371/journal.pone.0216834
|
| 12 |
Jing Gao, Rongmu Xia, Jianbo Chen, Jing Gao, Xianyang Luo, Chunlin Ke, Caihong Ren, Jiayi Li, Yanjun Mi. Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of JAK1/2-STAT3 and AKT/MDM2/p53 signaling pathways. Aging 2020; 12(7): 6240 doi: 10.18632/aging.103019
|
| 13 |
Xizhe Li, Xiaoxiong Xiao, Ruimin Chang, Chunfang Zhang. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry 2020; 121(1): 468 doi: 10.1002/jcb.29218
|
| 14 |
De-hui Qiao, Xue-mei He, Hui Yang, Yang Zhou, Xian Deng, Lian Cheng, Xiang-yu Zhou. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer. American Journal of Otolaryngology 2021; 42(2): 102920 doi: 10.1016/j.amjoto.2021.102920
|
| 15 |
Jiahui Wei, Ruiqing Wang, Yiran Lu, Song He, Yu Ding. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways. European Journal of Pharmacology 2022; 916: 174631 doi: 10.1016/j.ejphar.2021.174631
|
| 16 |
Xiao-Jie Xue, Fei-Rong Li, Jing Yu. Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line. World Journal of Gastroenterology 2021; 27(16): 1805-1815 doi: 10.3748/wjg.v27.i16.1805
|